Literature DB >> 16817030

Screening behavior in women at increased familial risk for breast cancer.

Yoland C Antill1, John Reynolds, Mary Anne Young, Judy A Kirk, Katherine M Tucker, Tarli L Bogtstra, Shirley S Wong, Tracy E Dudding, Juliana L Di Iulio, Kelly-Anne Phillips.   

Abstract

This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a familial cancer clinic (FCC). Self-report questionnaires assessing recall of screening advice, tests undertaken, risk perception, anxiety (Impact of Events Scale) and demographics were mailed to 396 consecutive eligible women who had attended one of six FCCs a median of 3.6 years prior. Family history, genetic test results and screening recommendations were abstracted from medical records. 182/266 (68.4%) women responded with 130 lost to follow-up. The proportions of women undertaking at least the recommended frequency of screening tests were: breast self examination (BSE) 50.4%, clinical breast examination (CBE) 66.0%, mammography 82.2%, transvaginal ultrasound (TVUS) 70.0%, CA125 84.0%. Factors associated with adherence to screening were: higher anxiety for BSE and CBE, being BRCA1/2 positive for CBE, older age, method of arrangement and having at least one affected first degree relative for mammography. Factors significantly associated with over-adherence were higher scores for anxiety for BSE and CBE and younger age (< 40 years) for TVUS. Between 41.3% (BSE) and 57.6% (CBE) of women incorrectly recalled their screening recommendations. A substantial minority of high-risk women do not adhere to screening advice. Strategies to improve the accuracy of recall of recommendations and the uptake of recommended screening are required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817030     DOI: 10.1007/s10689-006-0006-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  39 in total

1.  Validity of women's self-reports of cancer screening test utilization in a managed care population.

Authors:  Lee S Caplan; David V McQueen; Judith R Qualters; Marilyn Leff; Carol Garrett; Ned Calonge
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

2.  Mammography use among sociodemographically diverse women: the accuracy of self-report.

Authors:  J G Zapka; C Bigelow; T Hurley; L D Ford; J Egelhofer; W M Cloud; E Sachsse
Journal:  Am J Public Health       Date:  1996-07       Impact factor: 9.308

3.  Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

Authors:  Jeffrey R Botkin; Ken R Smith; Robert T Croyle; Bonnie J Baty; Jean E Wylie; Debra Dutson; Anna Chan; Heidi A Hamann; Caryn Lerman; Jamie McDonald; Vickie Venne; John H Ward; Elaine Lyon
Journal:  Am J Med Genet A       Date:  2003-04-30       Impact factor: 2.802

4.  Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer.

Authors:  Claudine Isaacs; Beth N Peshkin; Marc Schwartz; Tiffani A Demarco; David Main; Caryn Lerman
Journal:  Breast Cancer Res Treat       Date:  2002-01       Impact factor: 4.872

5.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Authors:  B Thewes; B Meiser; I B Hickie
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

6.  Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.

Authors:  C Lerman; K Kash; M Stefanek
Journal:  J Natl Cancer Inst Monogr       Date:  1994

7.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Authors:  C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch
Journal:  Prev Med       Date:  2000-07       Impact factor: 4.018

8.  Early detection of familial ovarian cancer.

Authors:  A Dørum; G B Kristensen; V M Abeler; C G Tropé; P Møller
Journal:  Eur J Cancer       Date:  1996-09       Impact factor: 9.162

Review 9.  Fear, anxiety, worry, and breast cancer screening behavior: a critical review.

Authors:  Nathan S Consedine; Carol Magai; Yulia S Krivoshekova; Lynn Ryzewicz; Alfred I Neugut
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-04       Impact factor: 4.254

10.  Perception of risk in women with a family history of breast cancer.

Authors:  D G Evans; L D Burnell; P Hopwood; A Howell
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  15 in total

1.  Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling.

Authors:  Sharon L Bober; Lizbeth A Hoke; Rosemary B Duda; Nadine M Tung
Journal:  J Genet Couns       Date:  2007-08-04       Impact factor: 2.537

Review 2.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.

Authors:  Julianne M O'Daniel; Susanne B Haga; Huntington F Willard
Journal:  J Genet Couns       Date:  2010-03-30       Impact factor: 2.537

4.  Healthcare use after screening for lung cancer.

Authors:  Margaret M Byrne; Tulay Koru-Sengul; Wei Zhao; Joel L Weissfeld; Mark S Roberts
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

5.  Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer.

Authors:  Sima Ehsani; Roberta M Strigel; Erica Pettke; Lee Wilke; Amye J Tevaarwerk; Wendy B DeMartini; Kari B Wisinski
Journal:  Breast J       Date:  2015-03-17       Impact factor: 2.431

6.  Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.

Authors:  Michael A Campitelli; Anna M Chiarelli; Lucia Mirea; Lindsay Stewart; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight
Journal:  Eur J Cancer Prev       Date:  2011-11       Impact factor: 2.497

7.  Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

Authors:  Suzanne C O'Neill; Christine Rini; Rachel E Goldsmith; Heiddis Valdimarsdottir; Lawrence H Cohen; Marc D Schwartz
Journal:  Psychooncology       Date:  2009-10       Impact factor: 3.894

8.  The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer.

Authors:  Marijana Lijovic; Susan R Davis; Pam Fradkin; Jo Bradbury; Maria La China; Max Schwarz; Rory Wolfe; Helen Farrugia; Robin J Bell
Journal:  Fam Cancer       Date:  2009-02-17       Impact factor: 2.375

9.  Association between cancer risk perception and screening behavior among diverse women.

Authors:  Sue E Kim; Eliseo J Pérez-Stable; Sabrina Wong; Steve Gregorich; George F Sawaya; Judith M E Walsh; Celia P Kaplan
Journal:  Arch Intern Med       Date:  2008-04-14

10.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.